| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | Nov 22, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -3,650 | -1.13% | ✗ | $92.9K |
| Oct 23, 2024 | Oct 25, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -4,361 | -1.33% | ✗ | $128.8K |
| Oct 16, 2024 | Oct 18, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -2,860 | -0.87% | ✗ | $82.3K |
| Aug 21, 2024 | Aug 23, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -3,295 | -0.99% | ✗ | $105K |
| Jul 24, 2024 | Jul 26, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -4,015 | -1.19% | ✗ | $111.5K |
| Jul 17, 2024 | Jul 19, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -2,505 | -0.74% | ✗ | $74.4K |
| May 22, 2024 | May 24, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -3,242 | -0.94% | ✗ | $96.1K |
| Apr 24, 2024 | Apr 26, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -3,963 | -1.14% | ✗ | $114.5K |
| Apr 17, 2024 | Apr 19, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 40.0 | -9,827 | -2.75% | ✗ | $285.6K |
| Feb 22, 2024 | Feb 23, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -2,134 | -0.70% | ✗ | $77.1K |
| Jan 26, 2024 | Jan 29, 2024 | Immunovant, Inc. | Chief Legal Officer | Sell | 45.0 | -3,027 | -0.99% | ✗ | $114.8K |
| Nov 22, 2023 | Nov 24, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -3,252 | -1.05% | ✗ | $106.6K |
| Oct 25, 2023 | Oct 27, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -4,107 | -1.31% | ✗ | $142.3K |
| Aug 24, 2023 | Aug 25, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -12,286 | -3.76% | ✗ | $249.4K |
| Jul 26, 2023 | Jul 27, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -3,917 | -1.18% | ✗ | $84.7K |
| Apr 25, 2023 | Apr 26, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 48.8 | -2,633 | -0.79% | ✗ | $42.9K |
| Jan 26, 2023 | Jan 27, 2023 | Immunovant, Inc. | Chief Legal Officer | Sell | 42.5 | -10,156 | -3.97% | ✗ | $188K |
| Jun 1, 2017 | Jun 5, 2017 | Minerva Neurosciences, Inc. | SVP,General Counsel & Sec. | Sell | 10.0 | -17,500 | -100.00% | ✓ | $192.5K |
| Jan 4, 2017 | Jan 6, 2017 | Minerva Neurosciences, Inc. | SVP,General Counsel & Sec. | Sell | 10.0 | -17,500 | -100.00% | ✓ | $210K |